From a molecular point of view, the most frequently mutated genes in IPMN are GNAS (guanine nucleotide binding protein, alpha stimulating) and KRAS, which are altered in up to 60% and to 80% of cases, respectively [12,20,21]. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.